Codexis exits the cellulase enzyme market

November 19, 2013 | Analyst Insight

During Codexis’ Q3 2013 quarterly earnings announcement last week, John Nicols, President and CEO, reported a 44% decrease (to $3.9 million from $7 million) in revenue from Q2 2013...